114,33 €
0,18 %heute
L&S, 29. Februar, 09:37 Uhr
ISIN
US98956P1021
Symbol
ZBH
Berichte

Zimmer Biomet Holdings, Inc. Aktie News

Neutral
PRNewsWire
7 Tage alt
The ROSA® Shoulder System Becomes the First-to-Market Robotic Surgical Assistant for Shoulder Arthroplasty and the Fourth ROSA Robotics Application in Five Years WARSAW, Ind., Feb. 22, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the ROSA® Shoulder System for...
Neutral
PRNewsWire
8 Tage alt
WARSAW, Ind. , Feb. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2024.
Neutral
PRNewsWire
17 Tage alt
-- Company's Recently Established Health Equity Division Leads Efforts to Address Disparities in Health Access and Outcomes --  WARSAW, Ind. , Feb. 12, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, signed the Global Health Equity Network's (GHEN) Zero Health Gaps Pledge, a commitment from CEOs across industries and regions for their o...
Neutral
PRNewsWire
17 Tage alt
-- Booth Highlights Include Persona® OsseoTi® Keel Tibia, a Preview of ROSA® Shoulder*, Pending 510(k) Clearance, and the HAMMR™ Automatic Hip Impaction System-- WARSAW, Ind. , Feb. 12, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is showcasing the latest innovations across its product portfolio at the 2024 an...
Neutral
Seeking Alpha
21 Tage alt
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2023 Earnings Call Transcript
Positiv
Reuters
21 Tage alt
Zimmer Biomet Holdings Inc forecast 2024 profit above Wall Street expectations on Thursday, betting on resilient demand for its medical devices, and said it had initiated a restructuring program late last year to cut costs.
Neutral
PRNewsWire
21 Tage alt
Fourth quarter net sales of $1.940 billion increased 6.3% and 6.1% on a constant currency1 basis Fourth quarter diluted earnings per share were $2.01; adjusted1 diluted earnings per share were $2.20 Full-year net sales of $7.394 billion increased 6.5% and 7.5% on a constant currency1 basis Full-year diluted earnings per share were $4.88; adjusted1 diluted earnings per share were $7.55 Company p...
Positiv
Seeking Alpha
24 Tage alt
Zimmer Biomet: Weight Loss Drug Concerns Are Overblown

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen